DR. CHARLES THOMAS HOPKINS, M.D

Plain English
This study created and tested a new tool called the Chronic Rhinosinusitis Control Test (CRCT) to help measure how well patients manage their chronic rhinosinusitis (CRS). The CRCT has 8 questions and scores range from 0 to 31, with a lower score indicating better control; it was validated using feedback from 545 CRS patients and 23 expert doctors. The findings show that scores of 7 or lower are considered controlled, 8-15 are partly controlled, and 16 or higher indicate uncontrolled CRS, which is crucial for guiding treatment decisions. Who this helps: This tool benefits patients with chronic rhinosinusitis and their doctors by providing clear information on disease control.

Plain English
This study looked at how effective a medication called tezepelumab is for improving the sense of smell in patients suffering from chronic rhinosinusitis with nasal polyps (CRSwNP), a condition that can make it hard to smell. Among 408 participants, those treated with tezepelumab experienced significant improvements in their smell ability both after 4 weeks and 52 weeks, with the number of patients having no sense of smell dropping from 80% to about 31.5%. This matters because restoring the ability to smell can greatly enhance quality of life for these patients and reduce safety risks. Who this helps: This helps patients with chronic rhinosinusitis and nasal polyps.

Plain English
This study looked at patients with chronic rhinosinusitis (CRS) who had previously undergone sinus surgery to understand how much their sinuses were opened. Researchers found that among 114 patients, the average condition of their sinuses, measured by a specific score, was 12 out of a maximum of 24, indicating that many still had significant issues despite past surgeries. This is important because it shows that even with multiple surgeries, patients can still experience ongoing problems, highlighting the complexity of treating CRS. Who this helps: This helps patients with chronic rhinosinusitis and their doctors in understanding treatment outcomes.

Plain English
This study looked at how patients and doctors felt about a clinical trial comparing two treatments for chronic rhinosinusitis: surgery and medication. Researchers found that while surgery provided quick symptom relief for many patients, some had concerns about complications and recovery difficulties. This is important because it highlights the need for better communication and support for patients considering surgery, ensuring they feel informed and comfortable with their decisions. Who this helps: This helps patients with chronic rhinosinusitis and their healthcare providers.

Plain English
This study looked at the risks of using systemic glucocorticosteroids (sGCS) for treating chronic inflammatory diseases of the airways, like asthma. The researchers found that using between 500 mg and 1,000 mg of prednisolone, a common sGCS, significantly raises the chances of experiencing harmful side effects, with risks growing as the total dose increases. This matters because it highlights the need for careful prescription practices to avoid potential health problems from these medications, even when used in shorter courses. Who this helps: Patients with inflammatory airway diseases and their doctors.

Plain English
This study looked at what "remission" means for chronic rhinosinusitis (CRS), a long-lasting condition that affects the sinuses. The researchers found 39 different definitions of remission, most of which describe it as a state where the disease is either inactive or minimally active. They also noted that achieving remission could help prevent further damage to the patient's health. Who this helps: This research helps patients with chronic rhinosinusitis and their doctors by providing clearer expectations for treatment goals.

Plain English
This study examined how walking patterns (gait) after total knee replacement surgery relate to patient-reported experiences and physical performance over time. Researchers analyzed 12 studies involving 372 participants and found that as patients reported better quality of life and less pain, their walking also improved, with some correlations as high as 0.810. This is important because it shows that while patient feedback and walking ability improve together, they don't always measure the same aspects of recovery, highlighting the need for both types of assessments in rehabilitation. Who this helps: Patients recovering from total knee replacement surgery.

Plain English
This research focused on improving the definitions used to diagnose headaches and facial pain related to issues with the nose and sinuses. The researchers found that existing criteria sometimes overlap with primary headaches like migraines, leading to misdiagnoses. By refining these definitions, including evidence to support diagnoses, they aim to make it easier for doctors to accurately identify and treat the right conditions. Who this helps: This helps doctors and patients experiencing headache and facial pain.

Plain English
This study looked at how well hospitals communicate important health information about patients who were treated with a special life-support system called ECMO and then sent home. Out of 150 patients, 84% had a primary care doctor listed, and while most discharge summaries included basic details like the main diagnosis and medications, only 15.5% included specific recommendations for care after leaving the hospital. This is important because better communication can help primary care doctors provide the best possible support to these patients, who often face ongoing health challenges. Who this helps: This benefits patients and their primary care doctors.

Plain English
This study looked at a group of patients in Europe with a condition called chronic rhinosinusitis with nasal polyps (CRSwNP) to see how many qualified for biologic treatments based on international guidelines. Out of 206 patients analyzed, about 29% to 48% met the criteria for these treatments, with only 18.9% actually starting them. This is important because it highlights a gap between potential candidates for treatment and those who actually receive it, suggesting that national rules on medicine coverage influence treatment availability. Who this helps: This helps patients with chronic rhinosinusitis by identifying those who may benefit from more effective biologic treatments.

Plain English
This study looked at how changing rules for blood donation affected deferral rates for men who have sex with men (MSM) and the rates of infectious diseases like HIV and syphilis. It found that deferral rates for MSM dropped significantly from 0.150% under indefinite deferral to 0.067% after implementing individual donor assessments (IDA). Importantly, the change did not increase HIV, hepatitis B, or active syphilis rates, ensuring that blood safety was maintained even as rules became more flexible. Who this helps: This helps blood donors and patients who need blood transfusions by ensuring a larger pool of eligible donors while maintaining safety.

Plain English
This study looked at changes in hemoglobin (Hb) levels in blood donors over 15 years to understand how these changes affected the number of people who were turned away from donating due to low hemoglobin. Researchers found that from 2016 to 2023, the average hemoglobin levels in donors increased, and the percentage of women deferred for low Hb dropped from 12.2% to 7.7%. However, in 2024, after new testing equipment was introduced, the low-Hb deferral rates rose back to previous levels, highlighting the need for careful monitoring of donor hemoglobin trends to ensure safe blood donations. Who this helps: This helps blood donors and blood donation centers.

Plain English
The study looked at how to improve care for chronic respiratory diseases (CRDs) like asthma and COPD, which affect about one in three people in the West by 2025. At a meeting in Brussels, experts discussed ways to incorporate new medical innovations into everyday practice, improve collaboration among health professionals, and focus on personalized, preventive care to better support patients. The goal is to significantly enhance patient outcomes and reduce the impact of these diseases in the next decade. Who this helps: This helps patients with chronic respiratory diseases and their healthcare providers.

Plain English
The EUFOREA summit held in Brussels in February 2025 focused on improving care for patients with chronic respiratory conditions like asthma and allergies. Experts outlined the key research and educational goals for the next two years to better connect new scientific discoveries with everyday medical practice. This is important because it aims to close the gap in healthcare where patients often don’t receive the latest treatments they need. Who this helps: This benefits patients suffering from allergies and respiratory diseases, as well as their healthcare providers.

Plain English
This study looked at people who have a compulsive habit of picking their noses, known as rhinotillexomania, and the damage it can cause, specifically a condition called nasal septal perforation (NSP). Researchers found that out of 37 patients with this issue, 32 had nasal damage and that surgery to repair it was highly successful, with a 96.6% success rate, leading to noticeable improvements in symptoms and quality of life. This is important because it highlights the need for a specialized approach to treat both the behavior and the physical damage, which can greatly improve the well-being of affected individuals. Who this helps: This helps patients with rhinotillexomania and their doctors.

Plain English
This study looked at how well the drug dupilumab works for people with severe chronic sinus problems and a complete loss of smell (anosmia). Among the 724 patients treated, only 28.5% on dupilumab still had anosmia after 24 weeks, compared to 79.2% in the placebo group; additionally, 14.9% of the dupilumab group regained their sense of smell entirely. These findings are important because improved smell can greatly enhance a patient’s quality of life and may lead to better overall health outcomes. Who this helps: This benefits patients suffering from chronic sinus issues and anosmia.

Plain English
This study looked at the role of a protein called IL-25 in helping a specific type of immune cell, known as B cells, respond better during type 2 inflammation, which is common in conditions like asthma and chronic rhinosinusitis with nasal polyps (CRSwNP). The researchers found that when B cells were exposed to IL-25, they produced more antibodies, and B cells from nasal polyps showed higher levels of the IL-17RB receptor, linking this to how severe patients reported their symptoms. This is important because targeting the IL-25/IL-17RB pathway could lead to new treatments for people suffering from type 2 inflammation. Who this helps: This research benefits patients suffering from asthma and CRSwNP.

Plain English
This study looked at a new treatment goal for people with chronic rhinosinusitis with nasal polyps (CRSwNP), which is to achieve remission—a state where patients have no bothersome symptoms for at least a year and do not need medications or surgery. Researchers found that recent therapies, especially biologics, can help lessen persistent symptoms that traditional treatments struggle with. This is important because it provides a clearer objective for managing a condition that affects many people's quality of life. Who this helps: This helps patients suffering from chronic rhinosinusitis with nasal polyps.

Plain English
This research paper examines the use of biologic medications for adults suffering from severe airway inflammation, such as asthma and chronic sinusitis, especially when traditional treatments are not enough. The findings show that these drugs significantly improve symptoms and quality of life while reducing the need for surgeries and hospital visits. This is important because it offers new hope for patients who struggle to manage their conditions effectively. Who this helps: This helps patients with severe airway diseases and their doctors.

Plain English
This study looked at the effects of tezepelumab, a medication, on adults suffering from severe chronic sinus issues and nasal polyps. After 52 weeks, those taking tezepelumab reported a significant decrease in nasal polyps (2.07 points less than those on placebo), improved nasal congestion (1.03 points less), and a much lower need for surgery (only 0.5% needed it compared to 22.1% in the placebo group). These findings are important as they show that tezepelumab can effectively reduce symptoms and treatment needs for people dealing with these severe conditions. Who this helps: This helps patients with severe chronic rhinosinusitis and nasal polyps.

Plain English
This study looked at whether saline nasal irrigation could be a good alternative to antibiotics for adults with acute sinusitis. Out of 107 people invited, 81 (76%) agreed to participate, with 60% of those using saline instead of antibiotics compared to 38% in the usual care group. Most participants found saline nasal irrigation acceptable and many used it regularly, suggesting that it could be a helpful option for treating sinusitis without relying on antibiotics. Who this helps: This helps patients suffering from acute sinusitis.

Plain English
This study looked at a specialized program in the emergency department that trains paramedics and emergency medical technicians to use ultrasound to help patients with difficult intravenous access. The program improved patient care by speeding up access to veins, making the process less invasive, and enhancing the overall experience for patients. This matters because it helps ensure that patients who struggle with traditional IV placements receive timely and effective treatment. Who this helps: This benefits patients who have difficulty getting IVs and the medical staff providing their care.

Plain English
This study looked at the pain associated with fibrous dysplasia (FD), a rare condition that affects bones and causes painful lesions. Researchers found that mice with FD exhibited significant pain-related behaviors, which improved when they were given pain relief medication. Specifically, the FD mice showed increased inflammatory markers and nerve growth factors linked to pain, highlighting the biological processes behind the pain experienced by patients. Who this helps: This benefits patients with fibrous dysplasia who experience chronic pain.

Plain English
This study looked at how certain social and economic factors affect caregivers reporting that their children were significantly impacted by other people's drinking in Australia. Out of 705 caregivers, 5.4% said their child was substantially affected, with higher odds for women, single caregivers, and those experiencing financial stress or living in lower-income areas. This research shows that social disadvantages can negatively affect children's health regarding others' alcohol use and highlights the need for policies that provide financial support and address these issues. Who this helps: This benefits children and their caregivers, especially those facing financial hardships or living alone.

Plain English
This research paper discusses fibrous dysplasia/McCune-Albright syndrome (FD/MAS), a rare genetic condition caused by mutations in a specific gene that affect various body systems, particularly the bones. The study highlights that while these mutations lead to severe bone issues, including deformities and fractures, scientists have now identified how these gene changes trigger other symptoms and have developed promising treatment strategies. Understanding the mechanisms behind the disease is crucial for improving patient care and finding better therapies. Who this helps: This helps patients with fibrous dysplasia/McCune-Albright syndrome and their doctors.

Plain English
This study looked at how changing the way patients with end-stage renal disease (ESRD) receive dialysis affects their hospital visits. It found that patients who started receiving dialysis twice a week in the emergency department had significantly fewer hospital visits each month (1.44 down to 0.26) and fewer total hospital days (2.18 down to 1.20) compared to when they only had emergency dialysis. Patients who moved to standard outpatient dialysis experienced even better outcomes, with hospital visits dropping from 0.10 to 0.02 and total hospital days going down from 0.31 to 0.08. This matters because improving how dialysis is provided can lead to better health and fewer hospital stays for patients. Who this helps: This helps patients with end-stage renal disease who need dialysis.

Plain English
This study looked at the contamination of water in the United States by substances known as PFAS, which are harmful chemicals often found in products like firefighting foam and metal plating facilities. The research revealed that 94% of PFAS detections in groundwater exceeded safe levels, with the highest contamination linked to firefighting foam use. Understanding where these chemicals are found helps communities and regulators focus on cleaning up contaminated areas effectively. Who this helps: Patients, communities, and environmental health advocates.

Plain English
This study looked at a training program aimed at improving executive functioning in middle-aged and older people living with HIV to help reduce the inconsistencies in their cognitive abilities. The researchers will test this by training 120 participants for 20 hours over 10 to 12 weeks, comparing those who receive the training to a control group with no training. This is important because by reducing cognitive fluctuations, it may lead to better overall cognitive health for these individuals. Who this helps: This benefits patients living with HIV, particularly those experiencing cognitive difficulties.

Plain English
This study looked at how aware and prepared those involved in cancer clinical trials in Ireland are about making their work more environmentally friendly. Only 21% of cancer research professionals knew about key sustainability guidelines, and 86% were willing to participate in green initiatives despite feeling unsure about how to implement them. This is important because cancer trials are a significant source of greenhouse gas emissions, and improving their sustainability can help reduce their impact on climate change. Who this helps: This benefits patients, researchers, and the healthcare system by promoting a more sustainable approach to cancer treatment.

Plain English
This study compared the effectiveness of endoscopic sinus surgery and a course of the antibiotic clarithromycin in treating adults with chronic rhinosinusitis, a condition affecting the sinuses. Researchers involved 514 people and found that those who had surgery reported significantly better quality of life scores six months later compared to those who took clarithromycin or a placebo. This is important because it highlights surgery as a more effective treatment when standard medications don’t work, potentially guiding doctors in treatment decisions. Who this helps: This helps patients suffering from chronic rhinosinusitis and their doctors in deciding the best course of treatment.

Plain English
This study looked at patients with chronic rhinosinusitis (CRS) to understand their inflammation levels, particularly focusing on a type called type 2 inflammation. Researchers found that 78% of the 281 patients had high levels of eosinophils in their blood, which indicated more severe symptoms like loss of smell and nasal blockage. The study highlights the importance of measuring eosinophils to assess the severity of CRS, but it found that total IgE levels were not linked to symptom severity. Who this helps: This helps patients with chronic rhinosinusitis and their doctors in managing their condition.

Plain English
This study looked at a case where a blood transfusion transmitted the Babesia microti parasite, despite the blood being tested and marked as clean before the donation. A donor from Minnesota, who had previously tested positive for Babesia, gave blood again after being cleared, but their second donation turned out to be infected, leading to a possible transmission of the disease through a NAT-negative blood unit. This situation highlights gaps in the current blood testing methods and the ongoing risk of transfusion-transmitted infections, even when all safety measures seem to be in place. Who this helps: This information is important for blood banks, doctors, and patients receiving transfusions, especially in areas where Babesia is common.

Plain English
This study looked at the harmful effects of alcohol on people other than the drinker, including children and families, based on research from over 40 countries. It found that while there’s growing awareness of these harms, like domestic violence or accidents, the connection between alcohol laws and reducing these harms hasn't been fully explored. The findings are important because they highlight the need for better public policies and greater involvement from various stakeholders, such as employers, to minimize the negative impacts of alcohol on others. Who this helps: This helps patients and families affected by someone else's drinking, as well as public health advocates.

Plain English
This study looked at how cancer-induced bone pain (CIBP) affects the activity levels of mice with metastatic breast cancer. Researchers found that mice with cancer ran significantly less on wheels—averaging much shorter distances compared to healthy mice—indicating a clear link between increased pain and reduced activity. Specifically, the mice with cancer showed the shortest distances on the running wheels and poorer use of their limbs, suggesting that their ability to run was impacted by pain. Who this helps: This helps researchers and doctors who are developing new pain treatments for cancer patients.

Plain English
This study explored a new type of messenger RNA (mRNA) vaccine made from a mix of lipids and polymers, which could solve some problems seen with traditional lipid nanoparticles used in early mRNA vaccines. The researchers found that their new vaccine design not only led to strong immune responses in mice and golden hamsters, but also restricted the protein expression mostly to the muscle where it was injected, significantly reducing the SARS-CoV-2 virus in the nasal cavity better than traditional vaccines. This is important because it could enhance vaccine effectiveness while minimizing side effects. Who this helps: This helps patients and public health by improving vaccine options against COVID-19.

Plain English
This study looked at how men's drinking habits and ideas about masculinity are related to incidents of violence against female partners. It analyzed data from 20 studies and found that men who drink more frequently are 39% more likely to commit intimate partner violence, and those who strongly endorse masculine norms are 12% more likely to do so as well. This information is important because it helps identify specific risk factors that can inform prevention strategies to reduce violence against women. Who this helps: This helps victims of intimate partner violence and those working to prevent it, such as counselors and community programs.

Plain English
This study looked at how bone cancer, specifically osteosarcoma, affects sensory nerves in mice and how this relates to pain. Researchers found that mice with osteosarcoma had fewer myelinated sensory nerves in their bones, while certain other nerve types were more abundant near the bone's surface. This information is important because it can help develop new, targeted treatments for pain in bone cancer patients by understanding the nerve changes caused by the disease. Who this helps: Patients with bone cancer.

Plain English
This study looks at how climate change is affecting cancer care, particularly in vulnerable countries like the Philippines, Nigeria, and Brazil. It finds that extreme weather and pollution are increasing cancer cases and making outcomes worse, while healthcare contributes significantly to greenhouse gas emissions. The paper emphasizes the need for healthcare systems to adapt to these changes and offers strategies to make cancer care more eco-friendly. Who this helps: This research benefits patients, healthcare providers, and policymakers focused on improving cancer treatment while addressing environmental issues.

Plain English
This study looked at how diabetes patients in Wales are being treated for heart disease risk between 2010 and 2023. It found that more people are diagnosed with diabetes, rising from about 133,000 in 2010 to nearly 184,000 in 2023. However, fewer patients with heart disease are receiving cholesterol-lowering medications, dropping from 87.5% to 81.8%, and only about half of high-risk patients without heart disease are getting recommended treatment. Who this helps: This research benefits diabetes patients and their healthcare providers by highlighting gaps in treatment that need attention.

Plain English
This study looked at how men's heavy drinking hurts children by analyzing 19 articles published between 1990 and September 2023. It found that children's harms from their fathers' drinking fall into four main areas: family relationships, violence and abuse, health and psychological issues, and negative effects on education. For example, children can face direct harm from aggression and neglect or indirect harm when fathers are emotionally unavailable due to drinking, leading to problems like anxiety and behavioral issues. Who this helps: This benefits children affected by their fathers' alcohol use, as well as their families and healthcare providers.

Plain English
This study examined how women who survived breast cancer view their roles and identities after treatment. Researchers talked to six women who had been treated for breast cancer for over a year and discovered that while their identities remained intact, the effects of treatment made it harder for them to engage in daily activities they valued. Understanding these challenges is important because it can help improve support methods for women adapting to life after breast cancer. Who this helps: This helps breast cancer survivors and the healthcare providers supporting them.